BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15533610)

  • 1. Iloprost: an adjunctive approach to chronic viral hepatitis treatment.
    Zardi EM; Vespasiani Gentilucci U; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Afeltra A
    Med Hypotheses; 2005; 64(1):46-52. PubMed ID: 15533610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications.
    Zardi EM; Picardi A; Fazio VM; Ambrosino G; Dobrina A; Zullo M; Zennaro D; Afeltra A
    J Interferon Cytokine Res; 2004 May; 24(5):297-300. PubMed ID: 15153313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis in the elderly.
    Carrion AF; Martin P
    Am J Gastroenterol; 2012 May; 107(5):691-7. PubMed ID: 22290404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced portal flow velocity and volume following Iloprost treatment.
    Zardi EM; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Afeltra A; Frego M
    Acta Biomed; 2003; 74 Suppl 2():108-10. PubMed ID: 15055047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol and viral hepatitis: a mini-review.
    Gitto S; Micco L; Conti F; Andreone P; Bernardi M
    Dig Liver Dis; 2009 Jan; 41(1):67-70. PubMed ID: 18602355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic viral hepatitis.
    Dakhil N; Junaidi O; Befeler AS
    Mo Med; 2009; 106(5):361-5. PubMed ID: 19902718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis].
    Halank M; Ewert R; Opitz C; Seyfarth HJ; Höffken G
    Z Gastroenterol; 2006 Apr; 44(4):346-7; author reply 348. PubMed ID: 16708443
    [No Abstract]   [Full Text] [Related]  

  • 10. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
    Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC;
    Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of chophytol in complex treatment of patients with the chronic forms of hepatitis and cirrhosis of viral etiology].
    Kvitashvili MA; Okrostsvaridze NI; Chitaishvili KP
    Georgian Med News; 2006 Jun; (135):95-8. PubMed ID: 16905821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fibrosis and chronic viral hepatitis.
    Gutierrez-Reyes G; Gutierrez-Ruiz MC; Kershenobich D
    Arch Med Res; 2007 Aug; 38(6):644-51. PubMed ID: 17613356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of interferon in hepatitis B and C.
    Schalm SW
    Verh K Acad Geneeskd Belg; 2009; 71(1-2):87-99. PubMed ID: 19739400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central hemodynamics and microcirculation in viral hepatitis and chronic liver diseases].
    Belozerov ES; Kaukenova DU; Shabalin VV; Muratov BSh
    Ter Arkh; 1979; 51(12):27-9. PubMed ID: 538714
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
    Chevaliez S; Pawlotsky JM
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: Nucleoside analogues for the treatment of chronic hepatitis B.
    Younger HM; Bathgate AJ; Hayes PC
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1211-30. PubMed ID: 15606384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of viral hepatitis in children].
    Kekez AJ
    Acta Med Croatica; 2005; 59(5):463-7. PubMed ID: 16381244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term entecavir therapy of chronic severe hepatitis B.
    Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of hepatitis G virus infection on the course of chronic virus hepatitis B or C in children].
    Loś-Rycharska E; Szaflarska-Popławska A; Chrobot A; Czerwionka-Szaflarska M
    Wiad Lek; 2004; 57(9-10):421-6. PubMed ID: 15765755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.